在水溶液中的索福脂类和β-葡萄糖之间的相互作用
Hiroaki Kaga1,2, Masanori Orita2, Koji Endo2
1Department of Pure and Applied Chemistry, Faculty of Science and Technology, Tokyo University of Science.
Journal of oleo science
|February 4, 2024
概括
脂,天然的生物表面活性剂,阻止了β-葡萄糖的聚合,这是一个关键的生物膜成分. 与合成表面活性剂不同,脂在化品中的抗生物膜应用中提供了一个有希望的,环保的替代品.
科学领域:
- 生物化学 生物化学
- 微生物学 微生物学
- 化品科学 化品科学
背景情况:
- 皮肤疾病,如,亚托邦性皮肤炎和粉红疹,涉及微生物生物膜.
- 多糖对于生物膜的机械稳定性至关重要.
- 脂是具有潜在抗生物膜特性的生物表面活性剂,为石化表面活性剂提供了替代品.
研究的目的:
- 为了研究脂对β-葡萄糖的影响,一个模型生物膜多糖体.
- 了解在水溶液中的脂和β-葡萄糖之间的相互作用机制和结构变化.
主要方法:
- 动态光散射 (DLS) 用于评估β-葡萄糖聚合.
- 测量表面张力以研究界面相互作用.
- 异热定位热量计 (ITC) 用于确定结合热力学.
- 光学旋转以评估β-葡萄糖的结构变化.
主要成果:
- 脂分散β-葡萄糖,抑制聚合,不同于二硫酸盐 (SDS).
- 交互发生在溶液中,由疏水力驱动,而不是在空气-液体界面.
- 索福利皮德没有破坏β-葡萄糖的三重螺旋结构.
- 分散是由于固体阻碍和静电排斥而产生的,这些阻碍和电静电排斥来自于sophorolipids独特结构.
结论:
- 索法脂在β-葡萄糖上表现出独特的分散特性.
- 它们的相互作用机制涉及疏水力和固态/静电效应.
- 这些发现支持sophorolipids作为化品应用中的抗生物膜剂的有效性.
相关概念视频
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.4K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.4K
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
309
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
309


